AAIH Response to USPTO RFI

The AAIH welcomes the opportunity to comment on the US Patent and Trademark Office’s RFI: “Request for Comments on Patenting Artificial Intelligence Inventions” (Document Citation: 84 FR 51522, Document No: 2019-21190).

The AAIH is an international 501(c)4 not-for-profit multi-stakeholder advocacy organization, launched in 2019 to promote scientific, legislative, and regulatory initiatives necessary for the development, accessibility, and implementation of Artificial Intelligence (AI) powered healthcare solutions. Our mission is to enable the advancement and responsible use of AI in healthcare to improve patients’ lives by focusing on resolution of the sector’s most pressing and significant issues for patients and developers. It advances these goals by working collectively to identify and address industry wide concerns, one of which is the intersection of AI and intellectual property.